Maine 2025-2026 Regular Session

Maine House Bill LD538

Introduced
2/11/25  
Refer
2/11/25  
Refer
2/11/25  
Engrossed
5/20/25  
Enrolled
5/21/25  

Caption

An Act to Amend Maine's Prescription Drug Labeling Law by Allowing the Removal of the Name of a Prescriber of Mifepristone, Misoprostol and Their Generic Alternatives

Companion Bills

No companion bills found.

Previously Filed As

ME S08656

Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.

ME A10083

Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.

ME A10428

Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.

ME S00036

Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.

ME A02145

Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.

ME H0137

Amends existing law to classify mifepristone and misoprostol as schedule IV drugs.

ME SB01355

An Act Concerning Prescription Drugs, Devices And Nonlegend Drugs.

ME HB1724

Abortion pills; Prevention of Maternal Harm Act of 2025; coerced abortion; imprisonment; fines; Schedule IV; mifepristone and misoprostol; effective date.

ME HB1724

Abortion pills; Prevention of Maternal Harm Act of 2025; coerced abortion; imprisonment; fines; Schedule IV; mifepristone and misoprostol; effective date.

ME AB411

Revises provisions relating to prescription drugs. (BDR 54-1100)

Similar Bills

No similar bills found.